Nortis is developing the next generation of in-vitro systems that will allow scientists to better understand the causes of human disease. These systems represent urgently-awaited alternatives to animal testing, promising to drastically accelerate the discovery of new therapeutic drugs and the evaluation of toxic substances. Nortis’ in-vitro systems are based on small segments of tissues and organs grown from human-derived cells in disposable chip-like devices. This makes testing compounds faster, cheaper, and—most importantly—more predictive than animal testing. We anticipate that Nortis’ tissue-engineered in-vitro systems will become essential tools for finding cures for the most debilitating diseases of our time.